FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280616587> ?p ?o ?g. }

• W4280616587 endingPage "1503" @default.
• W4280616587 startingPage "1495" @default.
• W4280616587 abstract "Although rapid-acting insulins (RAIs) are used frequently in Korean clinical settings, evidence on their use is limited. This study explores the pattern and clinical effectiveness of the use of RAIs in Korean patients with type 2 diabetes mellitus (T2DM).This non-interventional, observational study enrolled patients (aged >18 years) with T2DM who were prescribed RAIs. The pattern of use and effectiveness of RAI analogs were evaluated over 6 months.A total of 299/451 patients were analyzed. Approximately 90% (n/N=270/299) of the patients received insulin glulisine, which significantly reduced their levels of glycated hemoglobin (HbA1c: n=270, mean± standard deviation [SD]; -1.16±6.02%, p=0.0017), fasting plasma glucose (n=40; mean±SD: -54.9±90.89 mg/dl, p=0.0005), and post prandial blood glucose (n=35, mean±SD: -89.46± 105.68 mg/dl, p<0.0001) at 6 months, with a corresponding increase in body weight (BW) (n=197, mean±SD:1.45±3.64 kg, p<0.0001). At 6 months, more patients receiving an intensive regimen (basal insulin+≥2 RAI injections/day) had HbA1c <7% than those receiving a non-intensive regimen (basal insulin+1 RAI injection/day) (20.69% vs 7.46%; p=0.0333); the corresponding reduction in HbA1c was also higher in patients receiving the intensive regimen (p<0.0001). About one-fourth patients (n/N=22/95) were switched to the intensive regimen (from 1 to ≥2 RAI injections/day), and only 4.41% (n/N=9/204) of the patients were switched to 1 RAI injection/day. The patients receiving the intensive regimen showed higher levels of HbA1c reductions (mean±SD: -1.27±1.96%) compared with the maintenance group-1 RAI injection/day (mean±SD: -0.72±1.66%) (p=0.0459), without a significant increase in BW and body mass index.The insulin glulisine intensification regimen showed glycemic target achievement and can be considered a therapeutic tool in the management of T2DM patients." @default.
• W4280616587 created "2022-05-22" @default.
• W4280616587 creator A5000043225 @default.
• W4280616587 creator A5006080567 @default.
• W4280616587 creator A5007348949 @default.
• W4280616587 creator A5013213401 @default.
• W4280616587 creator A5023268642 @default.
• W4280616587 creator A5037538832 @default.
• W4280616587 creator A5044151546 @default.
• W4280616587 creator A5070459257 @default.
• W4280616587 creator A5070489050 @default.
• W4280616587 creator A5079974729 @default.
• W4280616587 creator A5083444011 @default.
• W4280616587 creator A5085160602 @default.
• W4280616587 creator A5087000611 @default.
• W4280616587 date "2022-05-01" @default.
• W4280616587 modified "2023-10-18" @default.
• W4280616587 title "Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea" @default.
• W4280616587 cites W1934660672 @default.
• W4280616587 cites W1980055828 @default.
• W4280616587 cites W2002951458 @default.
• W4280616587 cites W2021160326 @default.
• W4280616587 cites W2060812966 @default.
• W4280616587 cites W2073977794 @default.
• W4280616587 cites W2089501913 @default.
• W4280616587 cites W2098130207 @default.
• W4280616587 cites W2105703888 @default.
• W4280616587 cites W2130720820 @default.
• W4280616587 cites W2147165687 @default.
• W4280616587 cites W2155172547 @default.
• W4280616587 cites W2765328237 @default.
• W4280616587 cites W2793972080 @default.
• W4280616587 cites W2793995825 @default.
• W4280616587 cites W2915807915 @default.
• W4280616587 cites W3004838676 @default.
• W4280616587 cites W3127769706 @default.
• W4280616587 cites W4235701932 @default.
• W4280616587 cites W4246340431 @default.
• W4280616587 cites W4251240079 @default.
• W4280616587 cites W4256525495 @default.
• W4280616587 doi "https://doi.org/10.2147/dmso.s334944" @default.
• W4280616587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35591905" @default.
• W4280616587 hasPublicationYear "2022" @default.
• W4280616587 type Work @default.
• W4280616587 citedByCount "1" @default.
• W4280616587 countsByYear W42806165872023 @default.
• W4280616587 crossrefType "journal-article" @default.
• W4280616587 hasAuthorship W4280616587A5000043225 @default.
• W4280616587 hasAuthorship W4280616587A5006080567 @default.
• W4280616587 hasAuthorship W4280616587A5007348949 @default.
• W4280616587 hasAuthorship W4280616587A5013213401 @default.
• W4280616587 hasAuthorship W4280616587A5023268642 @default.
• W4280616587 hasAuthorship W4280616587A5037538832 @default.
• W4280616587 hasAuthorship W4280616587A5044151546 @default.
• W4280616587 hasAuthorship W4280616587A5070459257 @default.
• W4280616587 hasAuthorship W4280616587A5070489050 @default.
• W4280616587 hasAuthorship W4280616587A5079974729 @default.
• W4280616587 hasAuthorship W4280616587A5083444011 @default.
• W4280616587 hasAuthorship W4280616587A5085160602 @default.
• W4280616587 hasAuthorship W4280616587A5087000611 @default.
• W4280616587 hasBestOaLocation W42806165871 @default.
• W4280616587 hasConcept C126322002 @default.
• W4280616587 hasConcept C134018914 @default.
• W4280616587 hasConcept C2777180221 @default.
• W4280616587 hasConcept C2777538456 @default.
• W4280616587 hasConcept C2778024521 @default.
• W4280616587 hasConcept C2779306644 @default.
• W4280616587 hasConcept C2781413609 @default.
• W4280616587 hasConcept C2910068830 @default.
• W4280616587 hasConcept C555293320 @default.
• W4280616587 hasConcept C71924100 @default.
• W4280616587 hasConcept C90924648 @default.
• W4280616587 hasConceptScore W4280616587C126322002 @default.
• W4280616587 hasConceptScore W4280616587C134018914 @default.
• W4280616587 hasConceptScore W4280616587C2777180221 @default.
• W4280616587 hasConceptScore W4280616587C2777538456 @default.
• W4280616587 hasConceptScore W4280616587C2778024521 @default.
• W4280616587 hasConceptScore W4280616587C2779306644 @default.
• W4280616587 hasConceptScore W4280616587C2781413609 @default.
• W4280616587 hasConceptScore W4280616587C2910068830 @default.
• W4280616587 hasConceptScore W4280616587C555293320 @default.
• W4280616587 hasConceptScore W4280616587C71924100 @default.
• W4280616587 hasConceptScore W4280616587C90924648 @default.
• W4280616587 hasLocation W42806165871 @default.
• W4280616587 hasLocation W42806165872 @default.
• W4280616587 hasLocation W42806165873 @default.
• W4280616587 hasOpenAccess W4280616587 @default.
• W4280616587 hasPrimaryLocation W42806165871 @default.
• W4280616587 hasRelatedWork W1966225706 @default.
• W4280616587 hasRelatedWork W1974106130 @default.
• W4280616587 hasRelatedWork W2016328345 @default.
• W4280616587 hasRelatedWork W2042819106 @default.
• W4280616587 hasRelatedWork W2048226041 @default.
• W4280616587 hasRelatedWork W2066345847 @default.
• W4280616587 hasRelatedWork W2068166803 @default.
• W4280616587 hasRelatedWork W2166209517 @default.
• W4280616587 hasRelatedWork W2171960002 @default.
• W4280616587 hasRelatedWork W2430205611 @default.

• next